Acadia Healthcare Company, Inc. $ACHC Shares Purchased by Principal Financial Group Inc.

Principal Financial Group Inc. lifted its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 112.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 442,943 shares of the company’s stock after purchasing an additional 234,107 shares during the quarter. Principal Financial Group Inc.’s holdings in Acadia Healthcare were worth $10,967,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in shares of Acadia Healthcare in the first quarter worth $1,600,000. Goldman Sachs Group Inc. increased its position in shares of Acadia Healthcare by 21.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock valued at $21,170,000 after acquiring an additional 121,444 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Acadia Healthcare by 8.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after acquiring an additional 27,207 shares during the last quarter. Janney Montgomery Scott LLC acquired a new stake in Acadia Healthcare during the 2nd quarter worth about $479,000. Finally, Aberdeen Group plc grew its stake in Acadia Healthcare by 220.8% during the 2nd quarter. Aberdeen Group plc now owns 348,117 shares of the company’s stock valued at $7,899,000 after purchasing an additional 239,595 shares during the last quarter.

Acadia Healthcare Price Performance

NASDAQ:ACHC opened at $15.53 on Thursday. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44. The company has a 50 day moving average price of $13.92 and a 200-day moving average price of $18.78. Acadia Healthcare Company, Inc. has a 1-year low of $11.43 and a 1-year high of $42.85. The firm has a market cap of $1.43 billion, a price-to-earnings ratio of 13.27, a price-to-earnings-growth ratio of 3.89 and a beta of 0.89.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft reduced their price objective on Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating for the company in a research note on Wednesday, December 3rd. Leerink Partners lowered shares of Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 3rd. Bank of America downgraded shares of Acadia Healthcare from a “neutral” rating to an “underperform” rating and dropped their price objective for the company from $21.50 to $13.00 in a report on Wednesday, December 3rd. Cantor Fitzgerald set a $17.00 target price on shares of Acadia Healthcare in a report on Wednesday, December 3rd. Finally, TD Cowen restated a “reduce” rating on shares of Acadia Healthcare in a research report on Friday, January 16th. Six analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $18.62.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.